Novel Approaches in the Treatment of Non-Small-Cell Lung Cancer
ByRafael Rosell, MD,Jose Miguel Sanchez, MD,Miquel Taron, PhD,A. O'Brate, PhD,J. I. Gutierrez, PhD,M. Monzo, MD, PhD,E. Felip, MD,Jose Javier Sanchez, MD,Vicente Alberola, MD
Published: | Updated:
A wealth of data indicates that certain genetic abnormalities can target specific cytotoxic drugs and intervene at an early step as a mechanism of resistance in the treatment of non-small-cell lung cancer. Therefore prescribing